To view this email as a web page, click here

Today's Rundown

Featured Story

Emergent BioSolutions CEO, founder head for the Hill as Congress probes production contracts, errors

By Fraiser Kansteiner

Emergent BioSolutions' top brass is headed to the Hill as part of an ongoing congressional probe into the company. The manufacturer has been in the crosshairs ever since a production snafu at its Baltimore, Maryland, plant ruined up to 15 million Johnson & Johnson COVID-19 vaccine doses.

read more

Top Stories

As data near, U.K. rethinks AstraZeneca COVID-19 antibody deal

By Nick Paul Taylor

The U.K. government has rethought plans to buy one million doses of an anti-SARS-CoV-2 antibody in development at AstraZeneca, according to anonymous sources quoted by Bloomberg. News of the rethink comes shortly before AstraZeneca is due to deliver late-phase data on the candidate.

read more

COVID-19 tracker: CDC advisers endorse Pfizer shot for adolescents; Emergent leadership called before Congress

By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner

A CDC committee of vaccine experts endorsed the use of Pfizer's BioNTech-partnered vaccine in adolescents. Emergent's top executives have been called to testify before lawmakers over manufacturing contracts and production errors. CDC confirms more cases of rare blood clots among J&J recipients. And more headlines.

read more

CMS requires nursing homes to report COVID-19 vaccination rates

By Robert King

CMS issued a final rule requiring nursing homes to report COVID-19 vaccination data to help determine if some facilities need more help.

read more

Trials ramping back up, but slow takeup of places remain a barrier: report

By Ben Adams

As the pandemic is being beaten back in the U.S. and U.K. (but is still rampant in other areas of the globe), clinical trials are able to get back on track, but slow enrollment is still an issue.

read more

Hospital groups press HHS to give out rest of relief funds, extend key deadline

By Robert King

Major hospital groups are asking the Department of Health and Human Services to extend a June 30 deadline for providers to use up COVID-19 relief funds and distribute the remaining funding.

read more

Publisher: Rebecca Willumson

Associate Publisher: Angelique Alcover

Advertise | Contact

Manage Your Subscriptions

Trouble with your subscription?
Contact Support

Privacy Policy

This email was sent to newsletter@newslettercollector.com as part of the Fierce Life Sciences email list